Combination Treatment for PTSD After the WTC Attack

世贸中心袭击后 PTSD 的联合治疗

基本信息

项目摘要

DESCRIPTION (provided by applicant): Posttraumatic Stress Disorder (PTSD) is a prevalent condition with high rates of disability and comorbidity. Recent surveys in the greater New York area suggest that there still thousands of 9/11-related cases of PTSD due to the severe exposure to the World Trade Center Attack. Previous research has shown that both behavior therapy (prolonged exposure) and, more recently, serotonin reuptake inhibitors (SSRIs), are effective for highly chronic PTSD. However, very little is known about treatment response in individuals with PTSD due to a terrorist act of this scale. In addition, no study has specifically examined the combination of these treatments in individuals with PTSD. Controlled trials from both behavior therapy and medication studies suggest that a substantial proportion of individuals with chronic PTSD benefit from treatment but remain symptomatic and functionally impaired. There are no studies to date that systematically investigate the combination of medication treatment with behavior therapy, although this approach is widely recommended in clinical practice. This study would therefore examine the value of providing SSRI treatment simultaneously with behavior therapy. The overarching goal is the study of maximization of treatment response for adults with chronic PTSD. Participants will be 100 adults with World Trade Center Attack related PTSD. All patients will be randomly assigned to receive either 10 sessions of exposure therapy plus paroxetine, or 10 sessions of exposure therapy plus placebo. Major assessments by an independent evaluator blind to randomization status will be conducted at baseline, week 5, and week 10. Responders to treatment will be continued on pill/placebo for an additional 12 weeks with assessments at week 14, week 18, and week 22. Assessments will focus on PTSD symptoms, general functioning, interpersonal problems, and comorbid anxiety and depressive symptoms. This study possesses several strengths. It examines the combination of two cost-effective, validated, complementary treatments in a new population with chronic PTSD (victims of a large scale terrorist attack). It then examines whether benefits remain or even continue to accrue through a maintenance phase. Findings may enhance public health through the study of maximization of treatment response for this serious and common psychiatric disorder.
描述(由申请人提供):创伤后应激障碍(PTSD)是一种流行的疾病,残疾和合并症的发生率很高。最近在大纽约地区进行的调查表明,由于严重暴露于世贸中心袭击事件,仍有数千例与9/11有关的创伤后应激障碍病例。以前的研究表明,行为疗法(长期暴露)和最近的血清素再摄取抑制剂(SSRIs)对高度慢性PTSD有效。然而,由于这种规模的恐怖行为,人们对PTSD患者的治疗反应知之甚少。此外,没有研究专门研究这些治疗在PTSD患者中的组合。来自行为疗法和药物研究的对照试验表明,相当一部分慢性PTSD患者从治疗中获益,但仍有症状和功能受损。迄今为止,还没有研究系统地研究药物治疗与行为疗法的结合,尽管这种方法在临床实践中被广泛推荐。因此,本研究将探讨SSRI治疗与行为疗法同时提供的价值。总体目标是研究慢性PTSD成人的治疗反应最大化。 参与者将是100名患有世贸中心袭击相关PTSD的成年人。所有患者将被随机分配接受10次暴露治疗加帕罗西汀或10次暴露治疗加安慰剂。将在基线、第5周和第10周由不了解随机化状态的独立评价者进行主要评估。治疗应答者将继续服用药丸/安慰剂额外12周,并在第14周、第18周和第22周进行评估。评估将集中在创伤后应激障碍症状,一般功能,人际关系问题,以及共病的焦虑和抑郁症状。 本研究具有几个优势。它研究了两种具有成本效益的,经过验证的,补充性治疗方法在慢性PTSD(大规模恐怖袭击的受害者)的新人群中的组合。然后,它检查是否仍然存在,甚至继续通过维护阶段积累的好处。研究结果可能会通过对这种严重和常见的精神疾病的最大化治疗反应的研究来加强公共卫生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Franklin R. Schneier其他文献

Franklin R. Schneier的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Franklin R. Schneier', 18)}}的其他基金

Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection
针对多巴胺介导的社会奖励敏感性来修复社会脱节
  • 批准号:
    10572245
  • 财政年份:
    2023
  • 资助金额:
    $ 46.44万
  • 项目类别:
Gaze-contingent music reward therapy for social anxiety
针对社交焦虑的注视相关音乐奖励疗法
  • 批准号:
    10624779
  • 财政年份:
    2018
  • 资助金额:
    $ 46.44万
  • 项目类别:
Gaze-contingent music reward therapy for social anxiety
针对社交焦虑的注视相关音乐奖励疗法
  • 批准号:
    10392334
  • 财政年份:
    2018
  • 资助金额:
    $ 46.44万
  • 项目类别:
Ventrostriatal Dopamine Release and Reward Motivation in MDD
MDD 中的腹纹状体多巴胺释放和奖励动机
  • 批准号:
    8891167
  • 财政年份:
    2014
  • 资助金额:
    $ 46.44万
  • 项目类别:
Ventrostriatal Dopamine Release and Reward Motivation in MDD
MDD 中的腹纹状体多巴胺释放和奖励动机
  • 批准号:
    8579490
  • 财政年份:
    2013
  • 资助金额:
    $ 46.44万
  • 项目类别:
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
米氮平和 SSRI 联合治疗 PTSD:安慰剂对照试验
  • 批准号:
    7978835
  • 财政年份:
    2010
  • 资助金额:
    $ 46.44万
  • 项目类别:
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
米氮平和 SSRI 联合治疗 PTSD:安慰剂对照试验
  • 批准号:
    8254449
  • 财政年份:
    2010
  • 资助金额:
    $ 46.44万
  • 项目类别:
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
米氮平和 SSRI 联合治疗 PTSD:安慰剂对照试验
  • 批准号:
    8103124
  • 财政年份:
    2010
  • 资助金额:
    $ 46.44万
  • 项目类别:
Neural circuitry of submissive behavior and treatment response in social anxiety
社交焦虑中顺从行为和治疗反应的神经回路
  • 批准号:
    7256857
  • 财政年份:
    2007
  • 资助金额:
    $ 46.44万
  • 项目类别:
Neural circuitry of submissive behavior and treatment response in social anxiety
社交焦虑中顺从行为和治疗反应的神经回路
  • 批准号:
    7394457
  • 财政年份:
    2007
  • 资助金额:
    $ 46.44万
  • 项目类别:

相似海外基金

Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
  • 批准号:
    2885806
  • 财政年份:
    2023
  • 资助金额:
    $ 46.44万
  • 项目类别:
    Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
  • 批准号:
    10772386
  • 财政年份:
    2023
  • 资助金额:
    $ 46.44万
  • 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    474619
  • 财政年份:
    2022
  • 资助金额:
    $ 46.44万
  • 项目类别:
    Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
  • 批准号:
    485965
  • 财政年份:
    2022
  • 资助金额:
    $ 46.44万
  • 项目类别:
    Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    466358
  • 财政年份:
    2022
  • 资助金额:
    $ 46.44万
  • 项目类别:
    Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
  • 批准号:
    402040
  • 财政年份:
    2019
  • 资助金额:
    $ 46.44万
  • 项目类别:
    Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
  • 批准号:
    18K16103
  • 财政年份:
    2018
  • 资助金额:
    $ 46.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
  • 批准号:
    377313
  • 财政年份:
    2017
  • 资助金额:
    $ 46.44万
  • 项目类别:
    Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
  • 批准号:
    9315111
  • 财政年份:
    2016
  • 资助金额:
    $ 46.44万
  • 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
  • 批准号:
    8734273
  • 财政年份:
    2013
  • 资助金额:
    $ 46.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了